drugset
drugset / Trial / NCT04258189

A Study of JNJ-64417184, Administered as an Oral Solution, in Healthy Participants

NCT04258189 ↗

Phase 1 Completed 16 enrolled Janssen Research & Development, LLC
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to assess the food effect on the single-dose pharmacokinetic (PK) of the JNJ-64417184 oral solution, administered as 2 different formulations, in healthy adult participants.

Timeline

Start
2020-02-11
Primary completion
2020-08-05
Completion
2020-08-05

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-64417184 Unknown — Oral

Indications

No indication recorded.